Becton Dickinson Profit Margin 2006-2019 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of December 31, 2019 is 4.96%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.455B $17.290B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $23.921B 9.38
AmerisourceBergen (ABC) United States $17.766B 11.92
Cooper (COO) United States $15.822B 24.40
Cardinal Health (CAH) United States $14.400B 8.99
Align Technology (ALGN) United States $13.919B 35.63
Laboratory Of America Holdings (LH) United States $12.275B 11.18
West Pharmaceutical Services (WST) United States $11.911B 49.78
Straumann Holding AG (SAUHF) Switzerland $10.890B 0.00
DENTSPLY SIRONA (XRAY) United States $8.355B 15.40
Henry Schein (HSIC) United States $6.759B 13.43
Merit Medical Systems (MMSI) United States $1.849B 22.78
SmileDirectClub (SDC) United States $1.618B 0.00
CONMED (CNMD) United States $1.610B 21.33
STAAR Surgical (STAA) United States $1.473B 68.25
Atrion (ATRI) United States $1.297B 35.44
Patterson (PDCO) United States $1.255B 8.73
Antares Pharma (ATRS) United States $0.376B 0.00
Invacare (IVC) United States $0.217B 0.00
Lifevantage (LFVN) United States $0.161B 13.53
Pro-Dex (PDEX) United States $0.063B 16.86
Milestone Scientific (MLSS) United States $0.055B 0.00
Retractable Technologies (RVP) United States $0.046B 17.63
Endologix (ELGX) United States $0.012B 0.00
Biolase (BIOL) United States $0.007B 0.00